Loading
Chronic Disease Management Strategies / Inflammatory Bowel Disease · Journal article
Frontiers in Medicine · August 5, 2026
A consensus or society position rather than new primary data.
This bibliometric analysis systematically examined 2,069 publications on ulcerative colitis comorbid with depression from 2006–2025, identifying research hotspots, institutional contributors, and emerging trends. The work maps the landscape of an active and growing field, showing that research priorities have shifted toward quality of life and drug safety beyond traditional epidemiology, with multidisciplinary approaches emerging as a frontier direction.
Bibliometric and visualization analysis. Published research articles and clinical trials on ulcerative colitis comorbid with depression indexed in WOSCC, Scopus, and PubMed.. n = 2,069. Global; publications from United States, United Kingdom, Canada identified as core contributors..
2,069 papers included in visualization analysis with 28 additional records from supplementary searching Publication numbers increased significantly in 2021 and have remained at relatively high levels United States, United Kingdom, and Canada identified as core research forces
Core research hotspots focus on epidemiological studies, drug safety, and side effect management; multidisciplinary combined treatment is identified as frontier direction
This analysis informs researchers and clinicians about emerging priorities in UC-depression research—notably the shift toward quality-of-life assessment and drug safety—and highlights the need for multidisciplinary collaboration. It does not evaluate clinical efficacy or guide treatment decisions directly.
A bibliometric analysis mapping research trends and gaps in UC-depression comorbidity; useful for research direction but not clinical evidence on intervention efficacy or harm.
As stated by the source record.
Quoted from the source exactly as published.
This analysis informs researchers and clinicians about emerging priorities in UC-depression research—notably the shift toward quality-of-life assessment and drug safety—and highlights the need for multidisciplinary collaboration. It does not evaluate clinical efficacy or guide treatment decisions directly.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
Background Depression is highly prevalent in patients with ulcerative colitis (UC), affecting prognosis and patients’ quality of life. While related studies grow rapidly, a systematic review of the development trends in this field is still lacking. Based on this, the present study used bibliometric and visualization analysis methods to systematically examine the research landscape, hot topics, and future directions in the global field of UC comorbid with depression. Methods Relevant literature published between January 1, 2006 and December 31, 2025 in the Web of Science Core Collection (WOSCC) and Scopus databases was retrieved. CiteSpace and VOSviewer software were used to analyze countries, journals, authors, references, and keywords, and co-occurrence network maps were generated. For complementary analysis, clinical trial articles published in PubMed over the same time period were retrieved. Results A total of 2,069 papers were included in the visualization analysis, with an additional 28 records identified through supplementary searching. In 2021, the number of publications increased significantly and has since remained at a relatively high level. International academic exchanges in UC comorbid with depression research are active, with the United States, the United Kingdom, and Canada being the core research forces in this field. Inflammatory Bowel Diseases is the most published and most representative professional journal. Bernstein, Charles N. and Mikocka-Walus, Antonina have published the highest number of studies, while Ananthakrishnan, Ashwin N. and Ford, Alexander C. have the highest academic influence. The co-citation network of references suggests that research in this field is based on backgrounds such as pain management, perceived stress, and psychiatry. Keyword analysis shows that core research hotspots focus on epidemiological studies, drug safety, and side effect management. Multidisciplinary combined treatment involving gastroenterology, psychiatry, and endocrinology is a frontier research direction. Conclusion External environmental stressors and intrinsic metabolic dysregulation are jointly reshaping the frontier landscape of this field. Beyond traditional epidemiological investigations, patient quality of life and drug safety have emerged as current research priorities. Future research should focus on generating a greater volume of clinical evidence and promoting multidisciplinary collaborative care, with the goal of improving patients’ quality of life and long-term prognosis.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.